Klaus Brendel, Raymond C Duhamel: Body implants of extracellular matrix and means and methods of making and using such implants. University Patents, Barbara A Shimei, Stanley Sacks, January 31, 1989: US04801299 (315 worldwide citation)

A sterile body implant is derived from a body structure having as its major protein component collagens in the form of extracellular matrix. The body structure is treated to remove cellular membranes, nucleic acids, lipids and cytoplasmic components. Such structures are implanted internally in the b ...

Abe Widra: Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same. University of Illinois Foundation, Barbara A Shimei, February 18, 1986: US04570629 (98 worldwide citation)

Hydrophilic biopolymeric copolyelectrolytes comprising (a) a water-soluble linear anionic protein polyelectrolyte component derived from keratin and (b) a water-soluble linear cationic biopolymer polyelectrolyte component derived from at least one biopolymer selected from the group consisting of col ...

Bernard Roizman, Leonard E Post: Recombinant methods and materials. University Patents, Barbara A Shimei, September 6, 1988: US04769331 (42 worldwide citation)

Specific DNA sequence insertions, deletions and substitutions (i.e., combinations of sequence deletion and insertion) in eukaryotic cell or viral genomes are stably effected through use of selectable DNA sequences comprising a herpesvirus thymidine kinase (tk) gene.

Gerald Caple, Richard G Layton: Prevention of freezing at moderate supercooling using biogenic ice nucleation inhibitors. University Patents, Barbara A Shimei, July 22, 1986: US04601842 (27 worldwide citation)

A biogenic ice nucleation inhibitor, derivable from a source plant which is normally subjected to freezing stress in its natural habitat, is employed for protecting light frost-sensitive plants against frost injury by inhibiting the ice-nucleating activity of the ice-nucleating bacteria normally pre ...

Stuart G Gordon: Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract. University Patents, George M Yahwak, Barbara A Shimei, July 24, 1984: US04461833 (18 worldwide citation)

A chromatographic procedure for the purification of a proteolytic procoagulant enzyme from extracts of human and animal tumors. The extracts are sequentially contacted with a first benzamide affinity chromatographic resin, an agarose filtration gel, a second benzamide affinity chromatographic resin ...

Cristina Alonso Alija, Markus Heil, Dietmar Flubacher, Paul Naab, Josef Pernerstorfer, Johannes Peter Stasch, Frank Wunder, Klaus Dembowsky, Elizabeth Perzborn, Elke Stahl: Aminodicarboxylic acid derivatives having pharmaceutical properties. Bayer Schering Pharma Aktiengesellschaft, Thomas C Blankinship, Barbara A Shimei, August 24, 2010: US07781470 (16 worldwide citation)

The invention relates to compounds of formulae (II), (IV), and (VI) as shown below, wherein the several variable groups are as defined in the specification and claims. Processes for making these materials, and methods for using them in the synthesis of compounds for treatment of cardiovascular disor ...

Jaromir Pastorek, Silvia Pastorekova, Miriam Zatovicova, Jan Zavada, Marta Ortova Gut, Zuzanna Zavadova: Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IXS coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes. Institute of Virology of the Slovak Academy of Sciences, Leona L Lauder, Joan C Harland, Barbara A Shimei, December 7, 2010: US07846673 (14 worldwide citation)

Disclosed herein is the discovery of a soluble MN/CA IX (s-CA IX) found in body fluids, such as, urine and serum. Soluble CA IX comprises the extracellular domain of CA IX or portions thereof. The predominant s-CA IX species is the extracellular domain comprising a proteoglycan-like (PG) domain and ...

Emil T Kaiser, Gregory R Moe: Novel peptide hormones with calcitonin-like activity. University Patents, Barbara A Shimei, May 5, 1987: US04663309 (11 worldwide citation)

Compounds of the formula: ##STR1## wherein R.sub.1 is a moiety selected from the group consisting of ##STR2## R.sub.2 -R.sub.22 are amino acid moieties wherein R.sub.2 is an optional moiety which when present is selected from the group consisting of Ser and Gly,

Ulf Brüggemeier, Petros Gatsios, Mark Meininghaus, Leila Telan, Elisabeth Woltering, Martina Wuttke, Hartmut Beck, Nils Griebenow, Frank Süβmeier, Niels Svenstrup, Axel Kretschmer, Marcus Bauser, Johannes Köbberling, Wahed Moradi, Siegfried Zaiss, Claudia Hirth Dietrich, Barbara Albrecht: Substituted [(phenylethanoyl)amino]benzamides. Bayer Schering Pharma Aktiengesellschaft, Thomas C Blankinship, Barbara A Shimei, August 17, 2010: US07776922 (8 worldwide citation)

The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of inflammatory disorders such as, for example, cutaneous, respiratory tract and ...